Skip to main content

Advertisement

Log in

Aortico-pulmonary paraganglioma showing remarkable regression with cyclophosphamide

  • CASE REPORT
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

The treatment of choice for mediastinal paraganglioma is complete surgical resection. Its local recurrence, however, is very difficult to treat surgically because it usually involves important structures of the mediastinum, such as the aorta and trachea. We report a 64-year-old woman with aortico-pulmonary paraganglioma who developed local recurrence after complete resection. The recurrent tumor responded dramatically to single-agent chemotherapy with cyclophosphamide, whereas it did not respond to radiotherapy or combination chemotherapy with mitomycin C, vindesine, and cisplatin. We therefore consider that single-agent chemotherapy with cyclophosphamide could be an alternative treatment for unresectable recurrent paraganglioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: November 21, 1997 / Accepted: March 18, 1999

About this article

Cite this article

Shimizu, T., Matsuzaki, Y., Onitsuka, T. et al. Aortico-pulmonary paraganglioma showing remarkable regression with cyclophosphamide. Int J Clin Oncol 4, 298–301 (1999). https://doi.org/10.1007/s101470050072

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s101470050072

Navigation